Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | DGKA | P23743 | 1/20 | 0.42 |
| ▸ | HTR2C | P28335 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | RAD52 | P43351 | 1/20 | 0.41 |
| ▸ | P2RY10 | O00398 | 4/20 | 0.40 |
| ▸ | GPR34 | Q9UPC5 | 2/20 | 0.40 |
| ▸ | FAAH | O00519 | 1/20 | 0.40 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.39 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1396441 | 1.00 | NAAA (0.47) | NAAAALDH1A1NPSR1MAPTMAPK1 | |
| SCHEMBL14514324 | 1.00 | NAAA (0.47) | NAAAALDH1A1NPSR1MAPTMAPK1 | |
| Hydrochloric Acid SCHEMBL3914765 | 0.98 | NPSR1 (0.48) | NAAAALDH1A1NPSR1MAPTMAPK1 | |
| Hydrochloric Acid SCHEMBL3914767 | 0.98 | NPSR1 (0.48) | NAAAALDH1A1NPSR1MAPTMAPK1 | |
| SCHEMBL1644712 | 0.94 | NAAA (0.55) | NAAANPSR1MAPTMAPK1L3MBTL1 | |
| SCHEMBL472925 | 0.94 | NAAA (0.55) | NAAANPSR1MAPTMAPK1L3MBTL1 | |
| SCHEMBL17231345 | 0.93 | NAAA (0.58) | NAAANPSR1MAPTMAPK1L3MBTL1 | |
| SCHEMBL9442151 | 0.93 | NAAA (0.58) | NAAANPSR1MAPTMAPK1L3MBTL1 | |
| SCHEMBL2283336 | 0.93 | NAAA (0.58) | NAAANPSR1MAPTMAPK1L3MBTL1 | |
| SCHEMBL2279558 | 0.93 | NAAA (0.58) | NAAANPSR1MAPTMAPK1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122037683-A | Waterproof coating modifying treatment method | 上海理工大学 | 2026-05-15 | — | — | CN | claimed |
| CN-122037683-A | Waterproof coating modifying treatment method | 上海理工大学 | 2026-05-15 | — | — | CN | disclosed |
| CN-118240279-A | Plasticizer, plastic composition and plastic product | 星欧光学股份有限公司 | 2024-06-25 | — | — | CN | disclosed |
| US-20220015393-A1 | APPLICATION OF ASPARTIC ACID DERIVATIVE IN PREPARING ANIMAL FEED ADDITIVE | Anipha Technologies Pty Ltd (AU) | 2022-01-20 | — | — | US | disclosed |
| EP-3512486-B1 | BLUE POWDER AND USE THEREOF IN COSMETICS | OREAL (FR) | 2020-10-21 | — | — | EP | disclosed |
| EP-3512486-A1 | BLUE POWDER AND USE THEREOF IN COSMETICS | L'Oreal (FR) | 2019-07-24 | — | — | EP | disclosed |
| CN-109689010-A | Blue powder and its purposes in cosmetics | 莱雅公司 | 2019-04-26 | — | — | CN | disclosed |
| WO-2018050504-A1 | BLUE POWDER AND USE THEREOF IN COSMETICS | L'OREAL (FR) | 2018-03-22 | — | — | WO | disclosed |
| US-9439986-B2 | Tricarbonyl technetium-99m, rhenium-185/187, or rhenium-188 labeled cyclic RGD derivatives and uses thereof | BIO IMAGING KOREA CO., LTD. (KR) | 2016-09-13 | — | — | US | disclosed |
| EP-2583966-B1 | TRICARBONYL TECHNETIUM-99M OR RHENIUM-188 LABEL RING RGD DERIVATIVE, A PREPARATION METHOD THEREOF, AND A PHARMACEUTICAL COMPOSITION CONTAINING THE DERIVATIVE AS AN ACTIVE INGREDIENT FOR USE IN THE DIAGNOSIS OR TREATMENT OF ANGIOGENESIS-RELATED DISEASES | BIO IMAGING KOREA CO LTD (KR) | 2016-08-10 | — | — | EP | disclosed |
| US-20070135385-A1 | Methyl indoxam; obesity; dietectics; antidiabetic agents; insulin resistance; non-insulin dependent diabetes; glucose intolerance; hypercholesterolemia; hypertriglyceridemia; anticholesterol agents; metabolic disorders; foods;bioavailability; side effect reduction | ILYPSA, INC. | 2007-06-14 | — | — | US | disclosed |
| US-20070135383-A1 | Phospholipase inhibitors, including multi-valent phospholipase inhibitors, and use thereof, including as lumen-localized phospholipase inhibitors | ILYPSA, INC. | 2007-06-14 | — | — | US | disclosed |
| WO-2007056279-A2 | PHOSPHOLIPASE INHIBITORS, INCLUDING MULTI-VALENT PHOSPHOLIPASE INHIBITORS, AND USE THEREOF, INCLUDING AS LUMEN-LOCALIZED PHOSPHOLIPASE INHIBITORS | ILYPSA, INC. (US) | 2007-05-18 | — | — | WO | disclosed |
| WO-2007056281-A2 | MULTIVALENT INDOLE COMPOUNDS AND USE THEREOF AS PHOSPHOLIPASE-A2 INHIBITORS | ILYPSA, INC. (US) | 2007-05-18 | — | — | WO | disclosed |
| WO-2007056184-A2 | AZAINDOLE COMPOUNDS AND USE THEREOF AS PHOSPHOLIPASE-A2 INHIBITORS | ILYPSA, INC. (US) | 2007-05-18 | — | — | WO | disclosed |
| EP-0927264-A1 | REGIOSELECTIVE alpha-HYDROLYSIS OF AMINO ACID DIESTERS USING PIG LIVER ESTERASE | NSC Technologies LLC (US) | 1999-07-07 | — | — | EP | disclosed |
| WO-1998008968-A1 | REGIOSELECTIVE α-HYDROLYSIS OF AMINO ACID DIESTERS USING PIG LIVER ESTERASE | NSC TECHNOLOGIES LLC (US) | 1998-03-05 | — | — | WO | disclosed |
| EP-0299362-B1 | PROCESS FOR PREPARING PYRIDINE-2,3- DICARBOXYLIC ACID COMPOUNDS | Daiso Co., Ltd. (JP) | 1991-12-04 | — | — | EP | disclosed |
| US-4948896-A | REACTING AN ENONE AND AN AMINODIESTER | DAISO CO., LTD. (JP) | 1990-08-14 | — | — | US | disclosed |
| EP-0299362-A1 | Process for preparing pyridine-2,3- dicarboxylic acid compounds | Daiso Co., Ltd. (JP) | 1989-01-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070135385-A1 | Methyl indoxam; obesity; dietectics; antidiabetic agents; insulin resistance; non-insulin dependent diabetes; glucose intolerance; hypercholesterolemia; hypertriglyceridemia; anticholesterol agents; metabolic disorders; foods;bioavailability; side effect reduction | GPR119, INMT, PNLIP | NAAA 1049/4885ALDH1A1 2180/4885NPSR1 2004/4885 |
| US-20070135383-A1 | Phospholipase inhibitors, including multi-valent phospholipase inhibitors, and use thereof, including as lumen-localized phospholipase inhibitors | PNLIP, PLA2G2E, PLA2G3 | NAAA 159/4885ALDH1A1 3723/4885NPSR1 1734/4885 |
| US-20220015393-A1 | APPLICATION OF ASPARTIC ACID DERIVATIVE IN PREPARING ANIMAL FEED ADDITIVE | AADAT, SLC1A5, SLC1A3 | NAAA 83/4885ALDH1A1 1813/4885NPSR1 2339/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.